Article Details
Retrieved on: 2022-11-28 09:07:14
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
LONDON (Reuters) - British drug discovery company C4X Discovery said AstraZeneca had signed a licence worth up $402 million to develop an oral ...
Article found on: whbl.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here